SCHECHTER JONATHAN received a stock award from PHARMACYTE BIOTECH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/12/2025ACC: 0001683168-25-009113
Director
Since Aug 2022
+145.73K
Net shares
Net buyer
$68.8K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
213.23K acquired · 67.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
300.0%
12/12/2025
50K→200K
Common Stock
Direct
Shares
−67.50K
Price / share
$1.02
Trade value
$68.85K
% of position
33.8%
12/12/2025
200K→132.50K
Total
Net shares
+82.50K
Net value
-$68.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | A · Award | +150K | — | — | 300.0% | 50K | 200K |
| Common Stock Direct | 12/12/2025 | F · Tax Withholding | −67.50K | $1.02 | $68.85K | 33.8% | 200K | 132.50K |
| Total | +82.50K | -$68.85K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
63.23K shares
Shares
+63.23K
Strike price
1.22
Held after
63.23K
Exercisable
—
4/25/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock63.23K shares | 4/25/2025 | A · Award | +63.23K | 1.22 | — | 63.23K |